We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

81 hedge funds and large institutions have $414M invested in Repros Therapeutics Inc. in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23% less call options, than puts

Call options by funds: $35.1M | Put options by funds: $45.3M

Holders
81
Holders Change
+81
Holders Change %
–
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
81
Increased
–
Reduced
–
Closed
–
Calls
$35.1M
Puts
$45.3M
Net Calls
-$10.2M
Net Calls Change
-$10.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$51.3M +$49.1M +2,778,654 New
Jennison Associates
2
Jennison Associates
New York
$42.1M +$40.3M +2,283,116 New
VAM
3
Visium Asset Management
New York
$33.7M +$32.2M +1,825,000 New
PHS
4
PFM Health Sciences
California
$24.3M +$23.2M +1,316,357 New
WC
5
Wexford Capital
Florida
$23.4M +$22.4M +1,266,680 New
QF
6
QVT Financial
New York
$22.1M +$21.9M +1,240,588 New
Franklin Resources
7
Franklin Resources
California
$19.6M +$18.8M +1,064,000 New
KCM
8
Kingdon Capital Management
New York
$13.2M +$12.7M +716,418 New
Citadel Advisors
9
Citadel Advisors
Florida
$12.6M +$12M +680,822 New
JHIU
10
Janus Henderson Investors US
Colorado
$11.7M +$11.2M +632,872 New
AllianceBernstein
11
AllianceBernstein
Tennessee
$11.2M +$10.7M +605,666 New
LOAMU
12
Lombard Odier Asset Management (USA)
New York
$10.4M +$9.98M +565,000 New
BIT
13
BlackRock Institutional Trust
California
$9.65M +$9.24M +522,926 New
Vanguard Group
14
Vanguard Group
Pennsylvania
$9.61M +$9.19M +520,658 New
DCM
15
Driehaus Capital Management
Illinois
$9.06M +$8.68M +491,350 New
BFA
16
BlackRock Fund Advisors
California
$8.59M +$8.22M +465,622 New
FCM
17
Farallon Capital Management
California
$7.9M +$7.56M +428,000 New
Barclays
18
Barclays
United Kingdom
$7.87M +$7.53M +426,598 New
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$6.87M +$6.58M +372,410 New
AQR Capital Management
20
AQR Capital Management
Connecticut
$6.28M +$6.01M +340,559 New
Millennium Management
21
Millennium Management
New York
$5.36M +$5.13M +290,454 New
State Street
22
State Street
Massachusetts
$5.23M +$5.01M +283,652 New
Northern Trust
23
Northern Trust
Illinois
$5.01M +$4.8M +271,631 New
SC
24
Sophrosyne Capital
New York
$4.89M +$4.69M +265,300 New
ICAP
25
Independence Capital Asset Partners
Colorado
$4.33M +$4.15M +234,959 New
1
2 3 4

RPRX Hedge Fund Activity: Q2 2013 in Review

81 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2013, worth a combined $414M.

Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.

  • 81 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $414M of Repros Therapeutics Inc. stock for Q2 2013.
  • 81 funds opened new Repros Therapeutics Inc. positions in Q2 2013 and 0 closed out, a net change of +81 holders.

Based on aggregated 13F filings for Q2 2013.